Home   >  
Apoptosis Pathway
  >  
Bcl2

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Bcl2

Chemical Structure Cat. No. Product Name CAS No.
BI-3802 Chemical Structure
 BCP41514 BI-3802 2166387-65-9 
BI-3802 is a BCL6 inhibitor, with an IC50 of ≤3 nM. BI-3802 shows an IC50 of 43 nM for the cellular BCL6.
Mcl1-IN-2 Chemical Structure
 BCP40301 Mcl1-IN-2 292057-76-2
Mcl1-IN-2, a hydroxyquinoline derivative, is an Mcl-1 inhibitor.
APG-2575 Chemical Structure
 BCP40069 APG-2575 APG2575
APG-2575 is a novel, orally administered small-molecule Bcl-2‒selective inhibitor.
BDA-366 Chemical Structure
 BCP39785 BDA-366 1909226-00-1
BDA-366 is a small-molecule Bcl2-BH4 domain antagonist, BDA-366, that binds BH4 with high affinity and selectivity.
S55746 Chemical Structure
 BCP39114 S55746 1448584-12-0
S55746 is an orally available BCL-2 specific inhibitor (Ki = 1.3 nM), displaying 70 to 400-fold selectivity for BCL-2 over BCL-XL.
Bcl-2-IN-2 Chemical Structure
 BCP36375 Bcl-2-IN-2 2383085-86-5
Bcl-2-IN-2 is a potent and selective Bcl-2 inhibitor with an IC50 of 0.034 nM and also inhibits Bcl-xL with an IC50 of 43 nM, showing >1000-fold selectivity for Bcl-2 over Bcl-xL.
BCL2 Degrader C5 Chemical Structure
 BCP36383 BCL2 Degrader C5 2378801-85-3
BCL2 Degrader C5 is a novel potent and selective degrader of Bcl-2.
Marinopyrrole A Chemical Structure
 BCP36069 Marinopyrrole A 1227962-62-0
Marinopyrrole A is a novel and specific Mcl-1 inhibitor with an IC50 value of 10.1 μM, and shows >8 fold selectivity than BCL-xl (IC50 > 80 μM).
BDA-366 Chemical Structure
 BCP25061 BDA-366 1821496-27-8
BDA-366 is a Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
Bz-423 Chemical Structure
 BCP25995 Bz-423 216691-95-1
Bz-423 is an F1F0-ATPase modulator. It acts by selectively killing autoimmune lymphocytes.
123下一页末页共 50 条记录 1 / 5 页 
0086-15971444841